PKI-166

• Description :

  PKI-166 is an oral inhibitor of EGF-R tyrosine kinase (IC50:0.7 nM) that is both effective and selective. PKI-166 can effectively inhibit the growth and metastasis of various human cancer cells including pancreatic cancer.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  330.38

• Molecular Formula :

  C20H18N4O

• Notes :

  Research use only, not for human use.

• Receptor :

  VEGFR

• CAS Number :

  187724-61-4